Derma Sciences (DSCI) to Acquire BioD in ~$77.8M Deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
Go back to Derma Sciences (DSCI) to Acquire BioD in ~$77.8M Deal
July 28, 2016 7:30 AM EDT
Immediately accretive transaction will bring four proprietary
high-margin product families and revenue of $22 million for the
trailing 12 months ended June 30, 2016
Will add 235 independent sales representatives and seven direct
sales representatives with no call-point or customer overlap
BioD shareholders to make concurrent $2 million equity investment
Conference call to be held today at 9:00 a.m. Eastern time
PRINCETON, N.J.--(BUSINESS WIRE)--
Derma Sciences, Inc. (Nasdaq: DSCI), a tissue... More
July 27, 2016 7:30 AM EDT
Company also realized $7.6 million of proceeds from the sale of
Comvita Limited common stock during the second quarter
PRINCETON, N.J.--(BUSINESS WIRE)--
Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company
focused on advanced wound and burn care, announces the signing of a
definitive agreement to sell its First Aid Division (FAD) to Dukal
Corporation for approximately $12.2 million, including inventory. Dukal
is a privately-held supplier of a broad range of best-in-class
disposable medical products and patient-care items for all medical
markets, with headquarters in... More
